TY  - JOUR
PY  - 2022//
TI  - Erratum to: The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasis (Expert Opinion on Investigational Drugs, (2017), 26, 2, (243-249), 10.1080/13543784.2017.1274734)
JO  - Health (London)
SP  - e263
EP  - e263
VL  - 26
IS  - 2
N2  - Due to an administrative error, an incomplete list of Guest Editors was published in Print for the special issue: Critical Suicide Studies Special Edition: Between Methodology and Ethics. The Guest Editors of this special issue are Amy Chandler, Rob Cover and Scott J Fitzpatrick. The online page of the special issue has been corrected. © The Author(s) 2022.<p /> <p>Language: en</p>
LA  - en
SN  - 1363-4593
UR  - http://dx.doi.org/10.1177/13634593221076602
ID  - ref1
ER  -